Pressure On Tecentriq: Bladder Cancer Heats Up With Opdivo Approval, Keytruda Filing

Merck's filings in bladder cancer span first-line and second-line treatment and include overall survival data. Roche also is getting ready to move Tecentriq to the frontline setting.